Development and Optimization of Ionic Strength-Responsive Lipid–Polymer Hybrid Nanoparticles for Buccal Protein Delivery

Abdelhameed, Eslam Ramadan Mostafa and Nooh, Mdrmah and Deák, Martin and Varga, Norbert and Csapó, Edit and Sovány, Tamás and Kristó, Katalin (2026) Development and Optimization of Ionic Strength-Responsive Lipid–Polymer Hybrid Nanoparticles for Buccal Protein Delivery. PHARMACEUTICS, 18 (6). No. 719. ISSN 1999-4923

Preview

Text pharmaceutics-18-00719.pdf - Published Version Available under License Creative Commons Attribution. Download (4MB) | Preview

Abstract

Background: Oral protein delivery is a major challenge in the field of pharmaceutical technology due to poor stability and limited permeability through intestinal barriers. Buccal delivery is a promising alternative with less restricting physiological conditions; however, low protein permeability is still a limiting factor. Multiple nanocarriers have been proposed to improve buccal protein delivery with lipid–polymer hybrid nanoparticles (LPHNs) combining the advantages of both polymeric and lipid-based systems. However, these conventional carriers rely on passive protein protection and lack adaptive release mechanisms. Objectives: This work aimed to develop and systematically optimize an ionic strength-responsive LPHN system that can minimize protein release in buccal ionic conditions while offering a triggered release in plasma after absorption. Methods: LPHNs were prepared by a two-step approach where polymeric cores of Eudragit-L100 were prepared by electrostatic complexation with Lysozyme (LYZ) followed by lipid shell formation by the ethanol injection method. Systematic optimization was performed using two-level factorial and central composite designs. Moreover, the ionic strength responsiveness and in vitro LYZ release were investigated in different ionic strength media. Results: The final optimized formulations, LPHNs and sodium deoxycholate-containing LPHNs (NaDC-LPHNs), exhibited a particle size of 257.2 ± 1.5 nm and 246 ± 5.7 nm, encapsulation efficiency of 69.89 ± 0.22% and 68.14 ± 0.16%, and high drug loading efficiency of 24.11 ± 0.06% and 23.65 ± 0.04%, respectively. Moreover, both formulations showed minimal protein release at low ionic strength (buccal-like) conditions while demonstrating a triggered release at higher ionic strength (plasma-like) conditions. Conclusions: The developed system may provide a promising smart strategy to improve buccal protein delivery by enhancing buccal protection and improving systemic delivery.

Actions (login required)

Edit Item